share_log

Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $62 Price Target

Moomoo 24/7 ·  Apr 12 07:03

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $62 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment